Read More 5 minute read Pharma Industry News Senhwa Biosciences strikes pivotal supply deal with BeOne Medicines for cold tumor breakthrough Senhwa Biosciences and BeOne Medicines announce a global clinical trial to tackle cold tumors. Find out how this deal could change cancer immunotherapy. bySrinathDecember 11, 2025